Drug Shortage Report for APO-NAPROXEN

Last updated on 2018-03-01 History
Report ID 24274
Drug Identification Number 00592277
Brand name APO-NAPROXEN
Common or Proper name NAPROXEN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) NAPROXEN
Strength(s) 500MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL & 500 BTL
ATC code M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-12-13
Estimated end date 2018-02-28
Actual end date 2018-02-28
Shortage status Resolved
Updated date 2018-03-01
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2018-03-01 English Compare
v10 2018-02-26 French Compare
v9 2018-02-26 English Compare
v8 2017-12-14 French Compare
v7 2017-12-14 English Compare
v6 2017-11-30 French Compare
v5 2017-11-30 English Compare
v4 2017-11-07 French Compare
v3 2017-11-07 English Compare
v2 2017-10-03 French Compare
v1 2017-10-03 English Compare

Showing 1 to 11 of 11